{
  "id": 19301789,
  "title": "London startup raises $60M for degraders aimed at Alzheimer’s protein tau",
  "url": "https://urgent.news/2026/11/10/london-startup-raises-60m-for-degraders-aimed-at-alzheimers-protein",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T07:00:29.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/london-startup-raises-60m-for-degraders-aimed-at-alzheimers-protein-tau/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Oyster Therapeutics has raised $60 million to develop pills that destroy pathogenic forms of tau, a brain protein implicated in Alzheimer’s disease. The Series A-2 funding was led by life-science venture capital fund 4BIO Capital ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Medical Xpress",
        "title": "Two newly identified protein forms may play a role in Alzheimer's",
        "url": "https://urgent.news/2026/11/09/two-newly-identified-protein-forms-may-play-a-role-in-alzheimers",
        "published": "2026-11-09T19:20:09.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}